Simple Western systems from ProteinSimple, a Bio-Techne brand, are the only fully automated western blotting solutions for protein detection and characterization, providing results in as little as 3 hours.  Cell Signaling Technology (CST) is a leader in the development of antibodies and other related reagents used to elucidate cell signaling pathways that dictate cellular behavior and impact human health.  CST has completed assay optimization and validation on the Simple Western platform for a number of their antibodies, making it easier than ever to develop new robust and quantitative immunoassays for the detection and quantification of phospho and total proteins.  Researchers who choose CST primary antibodies with Simple Western validation can simply dilute the antibody to the recommended dilution range found on the data sheet and product page. CST antibodies are compatible with the standard Simple Western protocol, which helps users seamlessly incorporate these rigorously validated antibodies into their existing workflows.

"We are excited to partner with Cell Signaling Technology as it combines the strengths of our respective companies to provide researchers with new, more quantitative ways to interrogate signaling pathways," commented Will Geist, President of Bio-Techne's Protein Sciences Segment. "The assay optimization efforts completed for this additional antibody catalog will help scientists get groundbreaking results even faster."

"Reproducibility has never been more important as more biotherapeutics advance to the clinic. We continue to strive to help scientists understand the disease mechanisms and signaling events responsible, and this partnership will help get the needed data faster.  Our partnership with Bio-Techne, and their Simple Western platforms, shows how we can form bridges for our common customers," said Roberto Polakiewicz, Cell Signaling Technology, Chief Scientific Officer.